TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$62.76
-1.98 (-3.06%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-40.8% upside
Low Target
$26.93
Average Target
$37.15
High Target
$48.45
Current Price
$62.76
Current
$62.76
$62.76
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Scenario Analysis
Bear Case
$26.93
-57.1%
Low target
Base Case
$37.15
-40.8%
Avg target
Bull Case
$48.45
+-22.8%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$68.73
-8.7% from high
52-Week Low
$22.06
+184.6% from low
50-Day SMA
$32.84
+91.1% vs SMA
200-Day SMA
$24.79
+153.2% vs SMA
RSI (14)
40.3
Neutral
Target vs 52W High
$37.15
-45.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |